Please login (Members) to view content or
(Nonmembers) this article.
5
Average: 5 (1 vote)
Article

5-Fluorouracil and Capecitabine: Assessment and Treatment of Uncommon Early-Onset Severe Toxicities Associated With Administration

Edith Brutcher
Deb Christensen
Melissa Hennessey Smith
Judy B. Koutlas
Jean B. Sellers
Tahitia Timmons
Joanna Thompson
CJON 2018, 22(6), 627-634 DOI: 10.1188/18.CJON.627-634

Background: Uncommon early-onset severe toxicities from 5-fluorouracil (5-FU) and capecitabine can be fatal if early warning signs are not recognized and treated promptly.

Objectives: This article delineates the differences between expected side effects and uncommon early-onset severe toxicities from 5-FU and capecitabine. It also provides background for understanding the reasons patients may develop these toxicities and reviews the efficacy of standard supportive care against a novel therapy (uridine triacetate).

Methods: A panel of nurses convened to review the literature about toxicities associated with 5-FU and capecitabine administration and determined methods to educate nurses about toxicities and treatment.

Findings: Standard supportive care for 5-FU and capecitabine toxicities is associated with high fatality rates. Uridine triacetate treatment within 96 hours of administration is associated with survival.

Members Only

Access to this article is restricted. Please login to view the full article.

Not a current ONS Member or journal subscriber?
Join/Renew Membership or